NYSE:SYK • US8636671013
The current stock price of SYK is 381.33 USD. In the past month the price increased by 6.82%. In the past year, price decreased by -1.26%.
ChartMill assigns a technical rating of 7 / 10 to SYK. When comparing the yearly performance of all stocks, SYK turns out to be only a medium performer in the overall market: it outperformed 40.64% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to SYK. While SYK has a great profitability rating, there are some minor concerns on its financial health.
Over the last trailing twelve months SYK reported a non-GAAP Earnings per Share(EPS) of 13.63. The EPS increased by 11.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 12.92% | ||
| ROA | 6.78% | ||
| ROE | 14.48% | ||
| Debt/Equity | 0.66 |
36 analysts have analysed SYK and the average price target is 433.16 USD. This implies a price increase of 13.59% is expected in the next year compared to the current price of 381.33.
For the next year, analysts expect an EPS growth of 10.94% and a revenue growth 9.03% for SYK
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.95 | 199.24B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.33 | 175.441B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.46 | 111.449B | ||
| BDX | BECTON DICKINSON AND CO | 11.58 | 51.993B | ||
| IDXX | IDEXX LABORATORIES INC | 43.82 | 51.841B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.72 | 47.817B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.73 | 38.306B | ||
| RMD | RESMED INC | 20.49 | 36.658B | ||
| DXCM | DEXCOM INC | 28.95 | 28.507B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 56,000 full-time employees. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
STRYKER CORP
1941 Stryker Way
Portage MICHIGAN 49002 US
CEO: Kevin A. Lobo
Employees: 56000
Phone: 12693852600
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 56,000 full-time employees. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
The current stock price of SYK is 381.33 USD. The price decreased by -0.88% in the last trading session.
STRYKER CORP (SYK) has a dividend yield of 0.94%. The yearly dividend amount is currently 3.36.
SYK has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SYK.
The Revenue of STRYKER CORP (SYK) is expected to grow by 9.03% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
STRYKER CORP (SYK) has a market capitalization of 145.83B USD. This makes SYK a Large Cap stock.